| East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More | Ben Fidler | 03/17/16 | Boston |
| Amgen Bests Sanofi-Regeneron In PCSK9 Patent Case, Losers Vow Appeal | Alex Lash | 03/16/16 | New York |
| West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More | Alex Lash | 10/08/15 | Boston |
| East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More | Ben Fidler | 08/28/15 | New York |
| East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More | Ben Fidler | 07/31/15 | Boston |
| Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact | Ben Fidler | 07/28/15 | New York |
| FDA OKs Cholesterol Fighter Praluent For More Patients Than Expected | Alex Lash | 07/24/15 | New York |
| East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More | Ben Fidler | 07/24/15 | Boston |
| With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program | David Holley | 07/09/15 | Texas |
| FDA Cuts Limit on Esperion Cholesterol Drug, Considers Competitors | David Holley | 07/07/15 | Detroit Ann Arbor |
| East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More | Ben Fidler | 06/12/15 | Boston |
| Rare Heart Disease Advocate: “I’m More Relieved Than I’ve Ever Been” | Alex Lash | 06/10/15 | National |
| Advisors to FDA: Approve New Cholesterol Drug, But With Caveats | Alex Lash | 06/10/15 | National |
| East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More | Ben Fidler | 01/30/15 | Boston |
